Thymosin Alpha-1

Thymosin Alpha-1 (Ta1) is a 28-amino-acid peptide that occurs naturally in the thymus gland. It is sold under the brand name Zadaxin and is approved in more than 35 countries as a prescription drug for hepatitis B, hepatitis C, and immune support in cancer patients. In the United States it is compounded. How it works: Thymosin Alpha-1 trains and balances the immune system. Specifically, it enhances T-cell function and immune resilience - the branches of immunity responsible for recognizing and clearing pathogens and abnormal cells. It does not simply suppress or stimulate; it modulates, helping an underactive immune system become more competent and helping an overactive one settle into a healthier balance. Who tends to use it: People whose primary goal is immune support, as well as those focused on longevity at a secondary level. It is commonly used in chronic infection, post-illness recovery, and immunosenescence (age-related immune decline) protocols. How it is taken: Thymosin Alpha-1 is given by subcutaneous (SC) injection. The general dose range is 1.5-3 mg, administered 2-3 times per week. Timing is flexible - it can be injected at any time of day. Cycle length spans 4-12 weeks depending on goals and clinical response. What to expect: The effects of immune modulation are not dramatic in the way that a stimulant is - they build over weeks. Many people notice reduced frequency of illness or improved recovery speed over a cycle. Safety: Thymosin Alpha-1 is one of the most extensively studied and well-tolerated peptides in this category. The record notes it is used in chronic infection and recovery protocols. There are no excludeIf flags. It pairs well with Thymalin and LL-37 in immune stacks. Your licensed provider in the PepDepo network will set your dose and cycle at consult based on your immune history and goals.